Zobrazeno 1 - 10 of 60 pro vyhledávání: '"Takao Orii"'
1
Akademický článek
A prospective stratified case-cohort study on statins and multiple adverse events in Japan.
Autor: Nobuhiro Ooba, Tsugumichi Sato, Akira Wakana, Takao Orii, Masaki Kitamura, Akira Kokan, Hideaki Kurata, Yoshihiro Shimodozono, Kenichi Matsui, Hiroshi Yoshida, Takuhiro Yamaguchi, Shigeru Kageyama, Kiyoshi Kubota
Publikováno v: PLoS ONE, Vol 9, Iss 5, p e96919 (2014)
PURPOSE: To assess the association between statins and diverse adverse events in Japanese population. METHODS: New users of statin who started statin after 6-month period of non-use were identified in 68 hospitals between January 2008 and July 2010.
Externí odkaz: https://doaj.org/article/cc32605692a6492d86746a8fd604cfd6
Zobrazit plný text záznamu
3
To reduce the number of incidents related to medicines -Toward that end
Autor: Takao ORII, Ryo Suzuki, Tomofumi Yamaguchi, Tadasato Sugita
Publikováno v: Hospital Administration and Medical Practices. 1
Objective: With the revision of the Pharmaceutical Affairs Law, it is required to ensure traceability by utilizing barcodes. Methods and Results: In this paper, we describe the usefulness of barcodes on dispensing and packaging units in preventing dr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2f2d309fecfcdc323f144c2cac9b94b
https://doi.org/10.54844/hamp.2022.0029
Zobrazit plný text záznamu
6
Establishment of the MID‐NET® medical information database network as a reliable and valuable database for drug safety assessments in Japan
Autor: Yu Matsuzaki, Takao Orii, Michio Kimura, Yoshiaki Uyama, Masaharu Nakayama, Mayuko Ujibe, Yoshiaki Fujimura, Hideto Yokoi, Kazuhiko Ohe, Takahiro Suzuki, Mari Kishiba, Fumitaka Takahashi, Koichiro Murata, Sayoko Harada, Eizaburo Sueoka, Naoki Nakashima, Mitsune Yamaguchi, Maiko Kawaguchi, Satomi Inomata
Publikováno v: Pharmacoepidemiology and Drug Safety
Purpose To establish a new medical information database network (designated MID-NET® ) to provide real-world data for drug safety assessments in Japan. Methods This network was designed and developed by the Ministry of Health, Labour and Welfare and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512d2848d77859f85e70ed0abf4b2e67
http://europepmc.org/articles/PMC6851601
Zobrazit plný text záznamu
7
The utilization and challenges of Japan's MID‐NET ® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies
Autor: Maori Itoh, Koichiro Murata, Hideto Yokoi, Chieko Ishiguro, Naoki Nakashima, Yoshiaki Uyama, Eizaburo Sueoka, Takao Orii, Michio Kimura, Masaharu Nakayama, Yoshiaki Fujimura, Kazuhiko Ohe, Takahiro Suzuki, Kaori Yamada
Publikováno v: Pharmacoepidemiology and Drug Safety. 28:601-608
PURPOSE To examine the potential role of Medical Information Database Network (MID-NET® ), a newly established Japanese medical information database network, in postmarketing drug safety assessments through the characterization of its advantages and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a67e9187319390147fa45ff115c52876
https://doi.org/10.1002/pds.4777
Zobrazit plný text záznamu
8
Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life
Autor: Ryuichi Ogawa, Hirokazu Nakayama, Takao Orii, Toshiaki Kato, Hirotoshi Echizen
Publikováno v: European Journal of Drug Metabolism and Pharmacokinetics. 44:77-82
Little is known about the pharmacokinetics of phenobarbital in terminally ill cancer patients. We investigated whether phenobarbital clearance alters depending on the length of survival. We retrospectively reviewed the clinical, laboratory, and thera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20491798d6c11d6132e3044d839d22be
https://doi.org/10.1007/s13318-018-0495-5
Zobrazit plný text záznamu
9
Current Status and Issues of Electronic Information Provision for Risk Minimization: Coordination between Electronic Medicine Notebook and Patient Drug Information
Autor: Takao Orii
Publikováno v: YAKUGAKU ZASSHI. 138:325-329
In the collaboration between community pharmacies and hospitals or clinics, the use of electronic medicine notebook may allow information sharing, including among out-of-network hospitals, clinics, and community pharmacies. For risk minimization, mob
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f477e2aca3599886acb47257b5863fde
https://doi.org/10.1248/yakushi.17-00185-4
Zobrazit plný text záznamu
10
Eculizumab Dosing Intervals Longer than 17 Days May Be Associated with Greater Risk of Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria
Autor: Kensuke Usuki, Hirotoshi Echizen, Takao Orii, Ryuichi Ogawa, Hirokazu Nakayama
Publikováno v: Biological & Pharmaceutical Bulletin. 39:285-288
Eculizumab given bi-weekly is widely recommended for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). We undertook a retrospective analysis on the medical records of 763 dosings of 14 PNH patients to investigate whether a threshold would e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a1dd5a7131661113a6751f7c78edf9d
https://doi.org/10.1248/bpb.b15-00703
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje